Order Article Reprints

Romero-González G, Bover J, Arrieta J, Salera D, Troya M, Graterol F, Ureña-Torres P, Cozzolino M, Di Lullo L, Cippà PE, et al. The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 2022; 11(14):3970. https://doi.org/10.3390/jcm11143970

Romero-González, Gregorio, Jordi Bover, Javier Arrieta, Davide Salera, Maribel Troya, Fredzzia Graterol, Pablo Ureña-Torres, Mario Cozzolino, Luca Di Lullo, Pietro E. Cippà, and et al. 2022. "The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease" Journal of Clinical Medicine 11, no. 14: 3970. https://doi.org/10.3390/jcm11143970

Romero-González, G., Bover, J., Arrieta, J., Salera, D., Troya, M., Graterol, F., Ureña-Torres, P., Cozzolino, M., Di Lullo, L., Cippà, P. E., Urrutia, M., Paúl-Martinez, J., Boixeda, R., Górriz, J. L., Ara, J., Bayés-Genís, A., Bellasi, A., & Ronco, C. (2022). The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease. Journal of Clinical Medicine, 11(14), 3970. https://doi.org/10.3390/jcm11143970